1954. Immunogenicity Against SARS CoV-2 Ancestral Strain and Variants of Two New COVID-19 Recombinant Adjuvanted Vaccines Compared to BNT162b2 As a Third Dose Following Two Doses of BNT162b2: a Single-Blinded Multicenter Randomized Controlled Trial

Open forum infectious diseases(2022)

Cited 0|Views15
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined